Sevre-Long 30 mg
Sevre-Long 30 mg is a medicine authorised by Swissmedic under authorisation number 53952. The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 30 January 1997 and the authorisation is valid without a time limit. ATC code N02AA01 places the medicine in the group Analgesics.
| Authorisation number | 53952 |
|---|---|
| Name | Sevre-Long 30 mg |
| Full name | Sevre-Long 30 mg, Kapseln retard |
| Authorisation holder | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AA01 |
| First authorisation | 30 January 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sevre-Long 30 mg, Kapseln retard | A+ | 30 January 1997 |
| 2 | Sevre-Long 60 mg, Kapseln retard | A+ | 30 January 1997 |
| 4 | Sevre-Long 120 mg, Kapseln retard | A+ | 30 January 1997 |
| 6 | Sevre-Long 200 mg, Kapseln retard | A+ | 30 January 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 30 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
| 38 | 30 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
| 1 | 100 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
| 46 | 30 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
| 2 | 100 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
| 54 | 30 | Kapsel(n) | N02AA01 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sevre-Long 30 mg authorised in Switzerland?
Yes. Sevre-Long 30 mg is authorised by Swissmedic under authorisation number 53952, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sevre-Long 30 mg have?
Sevre-Long 30 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Sevre-Long 30 mg?
The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.